Testing effectiveness (Phase 2)Study completedNCT03379675
What this trial is testing
Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Participants Infected With Respiratory Syncytial Virus
Who this might be right for
Respiratory Syncytial Virus Infections
Janssen Research & Development, LLC 72